Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Zacks News
Reasons to Retain Stericycle (SRCL) Stock in Your Portfolio
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships in the form of long-term contracts ranging from three to five years.
Accenture (ACN) to Benefit From ARZ Acquisition: Here's How
by Zacks Equity Research
The latest deal is expected to help Accenture (ACN) broaden its banking platform-as-a-service capabilities across Europe.
Reasons to Retain Waste Management (WM) Stock in Your Portfolio
by Zacks Equity Research
Waste Management (WM) continues to execute core operating initiatives targeting focused differentiation and continuous improvement.
6 Reasons to Buy Automatic Data Processing (ADP) Stock Now
by Zacks Equity Research
Acquisition strategy and initiatives to streamline and expand its business should drive Automatic Data Processing's (ADP) prospects.
Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now
by Zacks Equity Research
IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.
6 Reasons to Add Avis Budget (CAR) Stock to Your Portfolio Now
by Zacks Equity Research
Acquisitions, technology enhancement and fleet expansion bode well for Avis Budget (CAR).
Reasons to Add Paychex (PAYX) Stock to Your Portfolio Now
by Zacks Equity Research
Paychex's (PAYX) solid business model, diversified products and services, and strategic acquisitions boost top-line growth.
Green Dot (GDOT) Rides on Prolonged Partnership With Walmart
by Zacks Equity Research
Time-honored relationship with Walmart boosts Green Dot (GDOT).
Rollins' (ROL) Acquisitions Aid, Rising Expenses Ail
by Zacks Equity Research
Rollins (ROL) is a steady dividend payer with a balanced approach to organic and inorganic growth.
Reasons to Retain Rollins (ROL) Stock in Your Portfolio
by Zacks Equity Research
Rollins (ROL) is currently benefiting from strength in all of its business lines.
Reasons to Bet on Cross Country Healthcare (CCRN) Stock
by Zacks Equity Research
Cross Country Healthcare (CCRN) is currently benefiting from its investments in headcount and technology.
Here's Why Investors Should Retain Fiserv (FISV) Stock Now
by Zacks Equity Research
The recent acquisition of Finxact is expected to expand Fiserv's (FISV) account processing, digital and payments solutions.
Are Options Traders Betting on a Big Move in Cross Country (CCRN) Stock?
by Zacks Equity Research
Investors need to pay close attention to Cross Country (CCRN) stock based on the movements in the options market lately.
FTI Consulting (FCN) Rides on Low Debt, Investor-Backing Moves
by Zacks Equity Research
FTI Consulting's (FCN) stock is aided by a solid capital position and shareholder-friendly strategies.
Insperity (NSP) Announces a Dividend Hike, Cheers Investors
by Zacks Equity Research
Insperity's (NSP) shareholder-friendly move of approving a dividend raise not only instills investors' confidence in the stock but also positively impacts its earnings per share.
Reasons Why You Should Bet on Charles River (CRAI) Stock
by Zacks Equity Research
Solid business diversification and investor-friendly moves aid Charles River (CRAI) stock.
Republic Services' (RSG) Acquisitions Aid Despite Debt Burden
by Zacks Equity Research
Republic Services' (RSG) top line benefits from the favorable impact of its inorganic growth profile and organic strength. However, its debt load remains a woe.
Here's Why You Should Retain TransUnion (TRU) Stock for Now
by Zacks Equity Research
TransUnion's (TRU) gigantic treasure trove of data is its most distinguishing asset and also perhaps the biggest barrier to entry for competitors.
5 Broker-Friendly Stocks to Tide Over the Market Doldrums
by Maharathi Basu
We believe that broker-favorite stocks like Cross Country Healthcare (CCRN), American Airlines (AAL), ArcBest (ARCB), Clearwater Paper (CLW) and Avnet (AVT) should be on an investor's radar.
S&P Global (SPGI) Gains From Acquisitions Despite High Debt
by Zacks Equity Research
S&P Global's (SPGI) acquisition strategy to innovate, increase differentiated content and develop new products looks impressive.
Here's Why You Should Hold on to Envestnet (ENV) Stock for Now
by Zacks Equity Research
Envestnet's (ENV) business model ensures solid asset-based and subscription-based recurring revenue generation capacity.
5 Reasons Why You Should Invest in FTI Consulting (FCN) Stock
by Zacks Equity Research
FTI Consulting's (FCN) international operations should help expand its geographic footprint and contribute to top-line growth.
Here's Why You Should Retain WEX Stock in Your Portfolio
by Zacks Equity Research
WEX's strong organic growth and revenue stability boost the stock.
Reasons to Retain Trane Technologies (TT) in Your Portfolio
by Zacks Equity Research
Trane Technologies (TT) remains focused on improving its business operating system and innovation through business transformation initiatives.
Insperity (NSP) Up on Worksite Employee Growth, Expenses Ail
by Zacks Equity Research
Insperity's (NSP) top line continues to benefit from an increase in average number of worksite employees paid per month.